down arrow

Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002CP5
CNY
10.58
0.02 (0.19%)

Dec 04

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd.
Why is Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd. ?
1
With a fall in Operating Profit of -20.93%, the company declared Very Negative results in Mar 25
  • The company has declared negative results for the last 4 consecutive quarters
  • OPERATING CASH FLOW(Y) Lowest at CNY 53.65 MM
  • NET PROFIT(HY) At CNY 25.28 MM has Grown at -31.62%
  • ROCE(HY) Lowest at 4.11%
2
With ROE of 8.04%, it has a expensive valuation with a 2.58 Price to Book Value
  • Over the past year, while the stock has generated a return of 0.58%, its profits have fallen by -25.5%
  • At the current price, the company has a high dividend yield of 1
3
Underperformed the market in the last 1 year
  • The stock has generated a return of 0.58% in the last 1 year, much lower than market (China Shanghai Composite) returns of 15.18%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd.
4.75%
1.00
43.36%
China Shanghai Composite
14.77%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
34.34%
EBIT Growth (5y)
69.83%
EBIT to Interest (avg)
19.97
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.20
Sales to Capital Employed (avg)
1.36
Tax Ratio
48.75%
Dividend Payout Ratio
47.00%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.83%
ROE (avg)
6.21%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
32
Industry P/E
Price to Book Value
2.58
EV to EBIT
18.14
EV to EBITDA
12.59
EV to Capital Employed
2.80
EV to Sales
1.78
PEG Ratio
NA
Dividend Yield
1.01%
ROCE (Latest)
15.43%
ROE (Latest)
8.04%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
INTEREST COVERAGE RATIO(Q)

Highest at 6,151.76

PRE-TAX PROFIT(Q)

Highest at CNY 38.24 MM

NET PROFIT(Q)

Highest at CNY 24.21 MM

EPS(Q)

Highest at CNY 0.08

-13What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at CNY 53.65 MM

NET PROFIT(HY)

At CNY 25.28 MM has Grown at -31.62%

ROCE(HY)

Lowest at 4.11%

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.9%

RAW MATERIAL COST(Y)

Grown by 14.41% (YoY

Here's what is working for Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd.
Interest Coverage Ratio
Highest at 6,151.76
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Pre-Tax Profit
Highest at CNY 38.24 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit
Highest at CNY 24.21 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS
Highest at CNY 0.08
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Here's what is not working for Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd.
Inventory Turnover Ratio
Lowest at 2.9% and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Operating Cash Flow
Lowest at CNY 53.65 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Raw Material Cost
Grown by 14.41% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."